Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Synthesis and screening of clerodane diterpene analogues from 16 hydroxycleroda 3,13(14)-Z-diene 15,16-olide for potential anti-mycobacterial activity.

Autor: Sony Priya K; Pharmaceutical Chemistry Research Laboratory, Andhra university, Visakhapatnam, India., Sruthi Sri B; Pharmaceutical Chemistry Research Laboratory, Andhra university, Visakhapatnam, India., Patrick F K; Pharmaceutical Chemistry Research Laboratory, Andhra university, Visakhapatnam, India., Sangeeta G; Pharmaceutical Chemistry Research Laboratory, Andhra university, Visakhapatnam, India., Suvarna B P; Pharmaceutical Chemistry Research Laboratory, Andhra university, Visakhapatnam, India., Murali Krishna K M; Pharmaceutical Chemistry Research Laboratory, Andhra university, Visakhapatnam, India.

Publikováno v: Natural product research [Nat Prod Res] 2023 Nov 06, pp. 1-9. Date of Electronic Publication: 2023 Nov 06.

Evaluation of an AI Model to Assess Future Breast Cancer Risk.

Autor: Damiani C; From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.)., Kalliatakis G; From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.)., Sreenivas M; From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.)., Al-Attar M; From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.)., Rose J; From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.)., Pudney C; From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.)., Lane EF; From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.)., Cuzick J; From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.)., Montana G; From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.)., Brentnall AR; From the Center for Human Technologies, Istituto Italiano di Tecnologia, Via Melen 83, Genoa 16152, Italy (C.D.); Wolfson Institute of Population Health, Queen Mary University of London, London, UK (C.D., E.F.L., J.C., A.R.B.); Institute of Computer Science (ICS), Foundation of Research and Technology Hellas, Heraklion, Crete, Greece (G.K.); Joint for Director Breast Screening, University Hospitals Coventry and Warwickshire NHS Trust Coventry, Coventry, UK (M.S.); Department of Oncoplastic Breast Surgery, University Hospitals of Leicester NHS Trust, Leicester, UK (M.A.A.); Consumer member at National Cancer Research Institute, Breast Group, London, UK (J.R., C.P.); and University of Warwick, WMG, Coventry, UK (G.M.).

Publikováno v: Radiology [Radiology] 2023 Jun; Vol. 307 (5), pp. e222679.